We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.86B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.6B
AUM Growth
+$48.1M
Cap. Flow
-$19.5M
Cap. Flow %
-0.75%
Top 10 Hldgs %
37.12%
Holding
232
New
10
Increased
45
Reduced
101
Closed
15

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$22.1M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$14.7M
3
IBM icon
IBM
IBM
+$9.86M
4
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$9.81M
5
ORCL icon
Oracle
ORCL
+$9.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.5M
2
PEP icon
PepsiCo
PEP
+$12.1M
3
GILD icon
Gilead Sciences
GILD
+$9.61M
4
COL
Rockwell Collins
COL
+$4.97M
5
PG icon
Procter & Gamble
PG
+$4.81M

Sector Composition

Rank Sector Weight
1 Industrials 18.53%
2 Financials 16.35%
3 Communication Services 15.88%
4 Healthcare 13.72%
5 Consumer Staples 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSX icon
201
Phillips 66
PSX
$85.4B
$231K 0.01%
2,525
-333
-12% -$28.2K
USB icon
202
US Bancorp
USB
$99.9B
$223K 0.01%
4,165
-126
-3% -$6.59K
DTE icon
203
DTE Energy
DTE
$28.6B
$220K 0.01%
2,409
PPH icon
204
VanEck Pharmaceutical ETF
PPH
$998M
$219K 0.01%
3,800
HSBC icon
205
HSBC
HSBC
$354B
$218K 0.01%
4,821
TD icon
206
Toronto Dominion Bank
TD
$201B
$218K 0.01%
+3,880
New +$204K
MKL icon
207
Markel Group
MKL
$22.9B
$214K 0.01%
+200
New +$207K
VVC
208
DELISTED
Vectren Corporation
VVC
$207K 0.01%
+3,147
New +$197K
VPL icon
209
Vanguard FTSE Pacific ETF
VPL
$8.37B
$205K 0.01%
+3,000
New +$202K
ILF icon
210
iShares Latin America 40 ETF
ILF
$3.82B
$204K 0.01%
+5,800
New +$196K
QEP
211
DELISTED
QEP RESOURCES, INC.
QEP
$185K 0.01%
21,600
NWSA icon
212
News Corp Class A
NWSA
$15.4B
$181K 0.01%
13,640
CVE icon
213
Cenovus Energy
CVE
$54.8B
$168K 0.01%
16,792
LXRX icon
214
Lexicon Pharmaceuticals
LXRX
$1.09B
$167K 0.01%
13,618
AES icon
215
AES
AES
$10.5B
$123K ﹤0.01%
+11,185
New +$125K
MDR
216
DELISTED
McDermott International
MDR
$79K ﹤0.01%
3,600
-367
-9% -$7.36K
CFRX
217
DELISTED
ContraFect Corporation
CFRX
$17K ﹤0.01%
19
BIIB icon
218
Biogen
BIIB
$30.6B
-60,947
Closed -$16.5M
DKS icon
219
Dick's Sporting Goods
DKS
$18.9B
-59,810
Closed -$2.38M
EG icon
220
Everest Group
EG
$14.1B
-1,150
Closed -$293K
EXEL icon
221
Exelixis
EXEL
$13.1B
-9,000
Closed -$222K
IJH icon
222
iShares Core S&P Mid-Cap ETF
IJH
$127B
-6,055
Closed -$211K
KG
223
Kestrel Group
KG
$67M
-535
Closed -$119K
TEVA icon
224
Teva Pharmaceuticals
TEVA
$41.3B
-28,120
Closed -$934K
BBBY
225
DELISTED
Bed Bath & Beyond Inc
BBBY
-7,230
Closed -$220K

Similar funds

Klingenstein Fields & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Klingenstein Fields & Co held 232 positions worth $2.6B, up 1.9% from $2.55B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Klingenstein Fields & Co's Q3 2017 filing shows 10 new, 45 increased, 101 reduced and 15 closed positions. Its largest new stake was Applied Materials: 11,560 shares worth $602K. The largest sale was Biogen, an estimated $16.5M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

  • Klingenstein Fields & Co's largest Q3 2017 buy was Applied Materials: 11,560 shares worth $602K.
  • Klingenstein Fields & Co added most to Intel in Q3 2017, an estimated $22.1M increase.
  • Klingenstein Fields & Co's biggest Q3 2017 reduction was PepsiCo, cutting an estimated $12.1M.
  • Klingenstein Fields & Co fully exited Biogen in Q3 2017, selling an estimated $16.5M.
  • Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.6B portfolio in Q3 2017.
  • Klingenstein Fields & Co opened 10 new positions and closed 15 in Q3 2017.
  • Klingenstein Fields & Co's portfolio value rose 1.9% quarter-over-quarter to $2.6B.

Based on Klingenstein Fields & Co's 13F filing for Q3 2017, filed 1 Nov 2017.